A jury in Chicago on Thursday rejected an Illinois woman’s claim that the now discontinued heartburn drug Zantac caused her colon cancer, in the first trial out of thousands of lawsuits making ...

Zantac and ranitidine are routinely used by millions of heartburn sufferers. So how did the drug become a cancer risk?

CVS and Walgreens suspended sales of Zantac after the FDA said it found small amounts of a probable carcinogen. Here's what we know.

A jury in Chicago on Thursday rejected an Illinois woman’s claim that the now discontinued heartburn drug Zantac caused her colon cancer, in the first trial out of thousands of lawsuits making ...

Pharmaceutical company Sanofi announced Friday it's recalling over-the-counter Zantac a month after the Food and Drug Administration said the heartburn drug contains small amounts of a carcinogen.

The science that led to Zantac’s withdrawal is very different from the basis of the recently dismissed Zantac litigation (“The Zantac Scare and Junk Science,” Review & Outlook, Dec. 9). The ...

U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer ...

Zantac did not cause Brookfield woman's colon cancer, Cook County jury rules Jurors deliberated for just over four hours from Wednesday afternoon to Thursday morning. The three-week trial — a ...

Zantac exec testifies on claims that heat degraded heartburn drug into cancer-causing substance The plaintiff’s lawyers argue the drug degraded into NDMA when exposed to hot, humid conditions. A ...

The press typically treats lawsuits against business as inherently righteous and amplifies the junk science behind them. So in case you missed it, a federal judge on Tuesday dismissed claims that ...

The Delaware Supreme Court should uphold its state's reputation and reverse a lower court's acceptance of poor scientific evidence in a mass tort case.

The lawsuits were filed in state courts nationwide, but the agreements don’t completely resolve Pfizer’s exposure to claims linking Zantac and cancer.